Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Important Patent Score For Amarin

|Includes: Amarin Corporation PLC (AMRN)

Patent 13/417,899 - for Vascepa to be used in conjunction with Lipitor was given notice of allowance (NYSE:NOA). This is an important step in protecting the compound in use with popular statins, and vital to keep PFE in the game for a premium.

Maintain view of BO, $28-32 PT. Also see corresponding insta-blog post on scripts topic today.